
TSE:L
This summary was created by AI, based on 15 opinions in the last 12 months.
Loblaw Companies Ltd is the largest food and drug retailer in Canada, benefiting from its dominant market position, especially through strong private labels like No Name and the successful acquisition of Shoppers Drug Mart (SDM). The company has shown resilience amid inflation and rising costs, which have led to an increase in food prices, yet its focus on discount banners is resonating well with consumers seeking value. Analysts believe there's strong growth potential, particularly due to SDM's market share in pharmaceuticals and grocery. However, some experts caution that the stock is reaching its highest valuations in years, presenting a potential issue for future growth sustainability. While the technical aspects of the stock are favorable, there are concerns regarding competition from giants like Walmart and Costco, impacting its attractiveness at this valuation level.
Very few competitors, and those types of names tend to perform well long-term. Largest grocery retailer, so procures good prices and controls distribution. Shoppers Drug Mart provide lots of earnings. Loyalty programs doing well. As a consumer staple, won't participate with more cyclical names. Defensive part of your portfolio. If you're up nicely, you could take some profits.
Likes it. It's an inflation story. Some consumers are gravitating away from restaurants and back to buying their own food, so it's a volume story too. Good place to be. Trading at a reasonable 15x earnings, not overly expensive. If you think we're getting into a mild recession, which might be prolonged, this is a safe bet.
Consumer staples are defensive as we head into a slowing economy. Their discount banners are attracting customer traffic amid inflation. She likes their private labels with 25% customer penetration and strong margins. Great locations. Have benefited from the reopening as people return to the office. Drug stores will play a growing, bigger role in healthcare (Loblaw owns Shoppers Drug Mart and is well-positioned).
(Analysts’ price target is $137.05)
Defensive consumer staple going into economic slowdown. Over half of food banners are in discount, seeing increased traffic. Plus, more people are cooking at home rather than eating out. SDM has great locations, offers Loblaw products; pharmacists expanding roles, and this increases general traffic. Yield is 1.45%.
(Analysts’ price target is $135.40)